THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 117 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $24,874 | -36.3% | 2,773 | -20.1% | 0.00% | -50.0% |
| Q4 2023 | $39,025 | +30.2% | 3,472 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $29,963 | -16.6% | 3,472 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $35,935 | -21.5% | 3,472 | -14.9% | 0.00% | 0.0% |
| Q4 2022 | $45,755 | +23.8% | 4,078 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $36,947 | -5.2% | 4,078 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $38,986 | -71.3% | 4,078 | -66.8% | 0.00% | -50.0% |
| Q4 2021 | $135,926 | +143.9% | 12,301 | +63.3% | 0.00% | +100.0% |
| Q3 2021 | $55,737 | -79.5% | 7,532 | -43.4% | 0.00% | -75.0% |
| Q1 2021 | $271,718 | +7.3% | 13,313 | -6.6% | 0.00% | 0.0% |
| Q4 2020 | $253,276 | -15.3% | 14,253 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $299,170 | +5.1% | 14,253 | -2.5% | 0.01% | 0.0% |
| Q3 2019 | $284,681 | +19.3% | 14,614 | 0.0% | 0.01% | +25.0% |
| Q2 2019 | $238,647 | -28.0% | 14,614 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $331,299 | -11.4% | 14,614 | 0.0% | 0.01% | -14.3% |
| Q4 2018 | $373,972 | -40.2% | 14,614 | -20.6% | 0.01% | +75.0% |
| Q2 2014 | $625,000 | – | 18,407 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 8,511,350 | $72,176,248 | 9.12% |
| Newtyn Management, LLC | 2,124,703 | $18,017,481 | 3.38% |
| Irenic Capital Management LP | 2,760,948 | $23,412,839 | 2.86% |
| Weiss Asset Management LP | 7,457,060 | $63,235,869 | 2.39% |
| Oasis Management Co Ltd. | 1,157,965 | $9,819,543 | 2.21% |
| Park West Asset Management LLC | 1,700,000 | $14,416,000 | 1.06% |
| Baupost Group | 4,200,021 | $35,616 | 0.98% |
| Camber Capital Management LP | 1,000,000 | $8,480 | 0.24% |
| Virtus ETF Advisers LLC | 38,386 | $325,513 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 204,089 | $1,731 | 0.12% |